Long labour. Prolonged second stage (of labour)
Conditions
Interventions
Intervention 1: In the misoprostol group, a tablet of 200 µg was dissolved in 200cc of water and 25cc was administered every two hours for up to 24 hours. The maximum dose was 300 µg.
Fetal heart moni
Treatment - Drugs
In the misoprostol group, a tablet of 200 µg was dissolved in 200cc of water and 25cc was administered every two hours for up to 24 hours. The maximum dose was 300 µg.
Fetal heart monitoring and uter
Sponsors
Shahid Beheshti University of Medical Science
Eligibility
Sex/Gender
Female
Age
16 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: pregnancy between 36 and 42 weeks of gestation; a live singleton fetus in cephalic presentation; no history of uterine surgery; spontaneous onset of active labor with regular contractions; an effaced cervix dilated between 3 cm and 9 cm; a reassuring fetal heart rate (FHR) pattern. Exclusion criteria: nonreassuring FHR pattern; parity greater than five; any contraindication to labor or vaginal delivery or both; epidural analgesia; significant maternal cardiac; renal or hepatic disease; hypersensitivity to misoprostol or prostaglandin analogues.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The time from augmentation to vaginal delivery. Timepoint: 12 and 24 hours during labor. Method of measurement: data recording.;Mode of delivery. Timepoint: 12 and 24 hours during labor. Method of measurement: data recording. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fetal and neonatal status. Timepoint: peri labor phase. Method of measurement: data record.;Maternal complications. Timepoint: peri labor phase. Method of measurement: data record. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAida Moeini
Department of Obstetrics and Gynecology, Shahid Beheshti University of Medical Science
Outcome results
None listed